Antiabsence effects of safranal in acute experimental seizure models: EEG and autoradiography

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 11, Issue 3, 2008, Pages 1-14

  Sadeghnia, Hamid R ^a,d   Cortez, Miguel A ^c,d   Liu, Dick ^d   Hosseinzadeh, Hossein ^b   Carter Snead, O ^c,d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CYCLOHEXENE DERIVATIVE; SAFRANAL; TERPENE; UNCLASSIFIED DRUG;

ABSENCE; ANIMAL; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN; C57BL MOUSE; CHEMISTRY; CROCUS; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MALE; METABOLISM; METHODOLOGY; MOUSE; PATHOPHYSIOLOGY;

ANIMALS; AUTORADIOGRAPHY; BINDING SITES; BRAIN; CROCUS; CYCLOHEXENES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; EPILEPSY, ABSENCE; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, GABA-A; TERPENES;

EID: 58149119700     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j38g6j     Document Type: Article

References (42)

1. Berkovic, S.F., Andermann, F., Andermann, E., Gloor, P., Concepts of absence epilepsies: Discrete syndromes or biologic continuum? Neurology, 37:993-1000, 1987.
2. rd., Basic mechanisms of generalized absence seizures. Ann Neurol, 37:146-157, 1995.
3. Manning, J.P., Richards, D.A., Bowery, N.G., Pharmacology of absence epilepsy. Trends Pharmacol Sci, 24:542-549, 2003.
4. Futatsugi, Y., Riviello J.J. Jr., Mechanisms of generalized absence epilepsy. Brain Dev, 20:75-79, 1998.
5. Kostopoulos, G.K., Involvement of the thalamocortical system in epileptic loss of consciousness. Epilepsia, 42:13-19, 2001.
6. rd., Presynaptic gamma-hydroxybutyric acid (GHB) and gammaaminobutyric acidB (GABAB) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): a possible mechanism for the generation of absence-like seizures induced by GHB. J Pharmacol Exp Ther, 273:1534-1543, 1995.
7. Lin, F-H., Wang, Y., Lin, S., Cao, Z., Hosford, D.A., GABAB receptor-mediated effects in synaptosomes of lethargic (lh/lh) mice. J Neurochem, 65:2087-2095, 1995.
8. Richards, D.A., Lemos, T., Whitton, P.S., Bowery, N.G., Extracellular GABA in the ventrolateral thalamus of rats exhibiting spontaneous absence epilepsy: a microdialysis study. J Neurochem, 65:1674-1680, 1995.
9. Tarantilis, P.A., Tsoupras, G., Polissiou, M., Determination of saffron (Crocus sativus L.) components in crude plant extract using high performance liquid chromatography-UV-visible photodiode-array detection-mass spectrometry. J Chromatogr A, 699:107-118, 1995.
10. Hosseinzadeh H., Khosravan V., Anticonvulsant effects of aqueous and ethanolic extracts of Crocus sativus L. stigmas in mice. Arch Irn Med, 5:44-47, 2002.
11. Hosseinzadeh, H., Talebzadeh, F., Anticonvulsant evaluation of safranal and crocin from Crocus sativus in mice. Fitoterapia, 76:722-724, 2005.
12. Hosseinzadeh, H., Sadeghnia, H.R., Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J Pharm Pharm Sci, 8:394-399, 2005.
13. Loscher, W., Honack, D., Fassbender, C.P., Nolting, B., The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res, 8:171-189, 1991.
14. Loscher, W., New visions in the pharmacology of anticonvulsion. Eur J Pharmacol, 342:1-13, 1998.
15. van Luijtelaar, E.L.J.M., Coenen, A.M.L., Circadian rhythmicity in absence epilepsy in rats. Epilepsy Res, 2:331-336, 1988.
16. Coenen, A.M.L., Blezer, E.H.M., van Luijtelaar, E.L.J.M., Effects of the GABA-uptake inhibitor tiagabine on electroencephalogram, spike-wave discharges and behaviour of rats. Epilepsy Res, 21:89-94, 1995.
17. Snead, O.C. 3rd, Banerjee, P. K., Burnham, M., Hampson D., Modulation of absence seizures by the GABA(A) receptor: a critical role for metabotropic glutamate receptor 4 (mGluR4). J Neurosci, 20:6218-6224, 2000.
18. Snead, O.C. 3rd, Hechler, V., Vergnes, M., Marescaux C., Maitre, M. Increased gammahydroxybutyric acid receptors in thalamus of a genetic animal model of petit mal epilepsy. Epilepsy Res, 7:121-128, 1990.
19. Bischoff, S., Leonhard, S., Reymann, N., Schuler, V., Shigemoto, R., Kaupmann, K., Bettler, B., Spatial distribution of GABA(B)R1 receptor mRNA and binding sites in the rat brain. J Comp Neurol, 412:1-16, 1999.
20. rd., Gammahydroxybutyric acid (GHB) and gammaaminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence. Neuropharmacology, 47:1146-1156, 2004.
21. Carlson, B.X., Mans, A.M., Hawkins, R.A., Baghdoyan, H.A., Pentobarbital-enhanced [3H] flunitrazepam binding throughout the rat brain: An autoradiographic study. J Pharmacol Exp Ther, 263:1401-1414, 1992.
22. Wu, Y., Buzzi, A., Frantseva, M., Velazquez, J.P.L., Cortez, M., Liu, C., Shen, L., Gibson, K.M., Snead O.C., Status epilepticus in mice deficient for succinate semialdehyde dehydrogenase: GABAA receptor-mediated mechanisms. Ann Neurol, 59:42-52, 2006.
23. Snead, O.C. 3rd, Evidence for a G proteincoupled gamma-hydroxybutyric acid receptor. J Neurochem, 75:1986-1996, 2000.
24. Snead, O.C. 3rd, Evidence for GABAB-mediated mechanisms in experimental absence seizures. Eur J Pharmacol, 213:343-349, 1992.
25. Wong, C.G., Snead, O.C. 3rd, The GABA(A) receptor: Subunit-dependent functions and absence seizures. Epilepsy Curr, 1:1-5, 2001.
26. Snead, O.C. 3rd, The gamma-hydroxybutyrate model of absence seizures: Correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges. Neuropharmacology, 30:161-167, 1991.
27. Crunelli, V., Emri, Z., Leresche, N., Unraveling the brain targets of gamma-hydroxybutyric acid. Curr Opin Pharmacol, 6:44-52, 2006.
28. Snead, O.C. 3rd, Depaulis, A., Vergnes, M., Marescaux, C., Absence epilepsy: advances in experimental animal models. Adv Neurol, 79:253-278, 1999.
29. Holmes, G.L., Models for generalized seizures. Suppl Clin Neurophysiol, 57:415-424, 2004.
30. Posner, E., Pharmacological treatment of childhood absence epilepsy. Expert Rev Neurother, 6:855-862, 2006.
31. Hosseinzadeh, H., Sadeghnia, H.R., Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: Involvement of GABAergic and opioids systems. Phytomedicine, 14:256-262, 2007.
32. Sieghart, W., GABAA receptors: ligand-gated Clion channels modulated by multiple drug-binding sites. Trends Pharmacol Sci, 13:446-450, 1992.
33. Sieghart, W., Structure, pharmacology, and function of GABAA receptor subtypes. Adv Pharmacol, 54:231-263, 2006.
34. Monod, J., Wyman, J., Changeux, J.P., On the nature of allosteric transitions: a plausible model. J Mol Biol, 12:8-118, 1965.
35. Sieghart, W., Structure and pharmacology of gamma-aminobutyric AcidA receptor subtypes. Pharmacol Rev, 47:181-234, 1995.
36. Walters, R.J., Hadley, S.H., Morris, K.D., Amin, J., Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms. Nat Neurosci, 3:1274-1281, 2000.
37. Doble, A., GABA abolishes cooperativity between benzodiazepine receptors. Eur J Pharmacol, 83:313-316, 1982.
38. Chiu, T.H., Rosenberg, H.C., Allosteric modulation of flunitrazepam binding to rat brain benzodiazepine receptors by methyl betacarboline-3-carboxylate. J Neurochem, 44:306-309, 1985.
39. Paul, S.M., Skolnick, P., Rapid changes in brain benzodiazepine receptors after experimental seizures. Science, 202:892-893, 1978.
40. Syapin, P.J., Rickman, D.W., Benzodiazepine receptor increase following repeated pentylenetetrazole injections. Eur J Pharmacol, 72:117-120, 1981.
41. Ito, M., Chiu, T.H., Rosenberg, H.C., Effects of pentylenetetrazol on GABAA/ benzodiazepine/picrotoxinin receptor complexes in rat brain regions. Neurochem Res, 11:637-646, 1986.
42. Rocha, L., Ackermann, R.F., Engel J. Jr., Chronic and single administration of pentylenetetrazol modifies benzodiazepine receptor-binding: an autoradiographic study. Epilepsy Res, 24:65-72, 1996.